# A Study Of The Efficacy And Safety Of Anidulafungin Vs. Fluconazole In The Treatment Of Patients With Candidemia And/Or Other Forms Of Invasive Candidiasis

> **NCT01176058** · PHASE3 · TERMINATED · sponsor: **Pfizer** · enrollment: 17 (actual)

## Conditions studied

- Candidemia

## Interventions

- **DRUG:** Anidulafungin/Fluconazole

## Key facts

- **NCT ID:** NCT01176058
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2010-12
- **Primary completion:** 2011-11
- **Final completion:** 2011-11
- **Target enrollment:** 17 (ACTUAL)
- **Why stopped:** See termination reason in detailed description.
- **Last updated:** 2015-10-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01176058

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01176058, "A Study Of The Efficacy And Safety Of Anidulafungin Vs. Fluconazole In The Treatment Of Patients With Candidemia And/Or Other Forms Of Invasive Candidiasis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01176058. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*